Neurotech reports positive genomic analysis of NTI164 as part of Phase 1/2 PANDAS/PANS trial NTI164 shown to positively modify immune cell function and address gene translation dysregulation ...

The analysis revealed that NTI164 can modulate the expression of genes related to immune cell function in PANDAS/PANS patients, suggesting that the treatment can adjust the immune system's response.

Neurotech’s broad-spectrum cannabinoid drug shown to positively modify immune cell function and address gene translation dysregulation in children with PANDAS/PANS.